Jianmin Pharmaceutical Group Co.,Ltd.
SHH: 600976.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jun Wang
- Employees
- 2,497
- Headquarters
- Wuhan, China
- IPO year
- 2004
- Market cap
- CN¥5.0B
- Website
- https://www.whjm.com
Loading 600976…
Loading profile data…Frequently asked questions about 600976
What does Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) do?
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells Chinese medicines in China. It offers pediatric drugs under the Jianmin and Longmu brands. The company also provides OTC, medical, and health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. is headquartered in Wuhan, China.
Where does 600976.SS trade?
Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) trades on the Shanghai Stock Exchange.
What sector is 600976.SS in?
Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jianmin Pharmaceutical Group Co.,Ltd.?
Jun Wang is the chief executive officer of Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS).
Where is Jianmin Pharmaceutical Group Co.,Ltd. headquartered?
Jianmin Pharmaceutical Group Co.,Ltd. is headquartered in China.
Does 600976.SS pay a dividend?
Yes — Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) paid a trailing twelve-month dividend of CNY 0.90 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600976.SS go public?
Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) completed its initial public offering in 2004.